These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Ineffectiveness of L-DOPA on hyperprolactinemia induced with sulpiride]. Barreca T; Rolandi E; Masturzo P; Gianrossi R; Cicchetti V Boll Soc Ital Biol Sper; 1975 Jun; 51(12):755-8. PubMed ID: 1222098 [No Abstract] [Full Text] [Related]
8. [Prevention with sulpiride of the inhibitory effect of L-DOPA on prolactin secretion]. Rolandi E; Barreca T; Masturzo P; Polleri A Boll Soc Ital Biol Sper; 1975 Jun; 51(12):751-4. PubMed ID: 1222097 [No Abstract] [Full Text] [Related]
9. Loss of central nervous system component of dopaminergic inhibition of prolactin secretion in patients with prolactin-secreting pituitary tumors. Fine SA; Frohman LA J Clin Invest; 1978 Apr; 61(4):973-80. PubMed ID: 659585 [TBL] [Abstract][Full Text] [Related]
15. [Study of growth hormone under the effects of L-dopa in retardation of stature and acromegaly]. Fossati P; Asfour M; Fourlinnie JC; Cappoen JP; Dalle-Furnari MA; Brion-Brevan B Lille Med; 1976 Nov; 19(9):757-65. PubMed ID: 1004102 [No Abstract] [Full Text] [Related]
16. Study on growth hormone and prolactin secretions in myotonic dystrophy. Canal N; Smirne S; Comi G; Guidobono F; Pecile A; Caviezel F Acta Neurol Belg; 1982; 82(3):178-84. PubMed ID: 7051737 [TBL] [Abstract][Full Text] [Related]